SHRADALE LIMITED
Company registration number 09676488 (England and Wales)
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
SHRADALE LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
SHRADALE LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
114,667
130,667
Tangible assets
4
1,221,769
1,166,571
Biological assets
5
928,037
802,385
Investments
6
171,978
161,716
2,436,451
2,261,339
Current assets
Stocks
74,400
113,822
Debtors
7
103,042
92,064
Cash at bank and in hand
6,010
19,849
183,452
225,735
Creditors: amounts falling due within one year
8
(1,063,295)
(1,456,456)
Net current liabilities
(879,843)
(1,230,721)
Total assets less current liabilities
1,556,608
1,030,618
Creditors: amounts falling due after more than one year
9
(855,157)
(506,476)
Provisions for liabilities
(182,493)
(173,213)
Net assets
518,958
350,929
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
518,858
350,829
Total equity
518,958
350,929
SHRADALE LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2025
31 March 2025
- 2 -

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 6 November 2025 and are signed on its behalf by:
Mr T D Dale
Director
Company registration number 09676488 (England and Wales)
SHRADALE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
1
Accounting policies
Company information

Shradale Limited is a private company limited by shares incorporated in England and Wales. The registered office is Little Shrawardine Farm, Ford, Shrewsbury, Shropshire, SY5 9NE.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
Nil
Leasehold improvements
5% straight line
Plant and equipment
10% reducing balance
Motor vehicles
17.5% reducing balance
SHRADALE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Biological assets

Biological assets are recognised only when three recognition criteria have been fulfilled:

- the entity has control over the asset as a result of past events;

- it is probable that future economic benefits associated with the asset will flow to the entity; and

- the fair value or cost of the asset can be measured reliably.

The company measures biological assets at cost less accumulated depreciation and accumulated impairment losses.

In respect of agricultural produce harvested from a biological asset, this is measured at the point of harvest at either;

- lower of cost and estimated selling price less costs to complete and sell; or

- fair value less costs to sell with any gain or loss arising on initial recognition of agricultural produce at fair value less costs to sell being included in profit or loss.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Dairy herd
Not depreciated
Beef
Not depreciated
Dairy replacements
Not depreciated
1.6
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

1.7
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.8
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

SHRADALE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 5 -
1.9
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.10
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.11
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.12
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.13
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

1.14
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.15
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

SHRADALE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 6 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
6
5
3
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2024 and 31 March 2025
160,000
Amortisation and impairment
At 1 April 2024
29,333
Amortisation charged for the year
16,000
At 31 March 2025
45,333
Carrying amount
At 31 March 2025
114,667
At 31 March 2024
130,667
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 April 2024
485,278
822,126
1,307,404
Additions
22,318
118,215
140,533
Disposals
-
0
(20,000)
(20,000)
At 31 March 2025
507,596
920,341
1,427,937
Depreciation and impairment
At 1 April 2024
1,048
139,785
140,833
Depreciation charged in the year
838
70,404
71,242
Eliminated in respect of disposals
-
0
(5,907)
(5,907)
At 31 March 2025
1,886
204,282
206,168
Carrying amount
At 31 March 2025
505,710
716,059
1,221,769
At 31 March 2024
484,230
682,341
1,166,571
SHRADALE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 7 -
5
Biological assets
Dairy herd
Beef
Dairy replacements
Total
£
£
£
£
Cost
At 1 April 2024
688,210
30,475
83,700
802,385
Additions - home reared
48,000
115,932
36,540
200,472
Reclassification
-
0
-
0
(48,000)
(48,000)
Disposals
(135,630)
(30,475)
-
0
(166,105)
Revaluation
54,625
-
0
84,660
139,285
At 31 March 2025
655,205
115,932
156,900
928,037
Depreciation and impairment
At 1 April 2024 and 31 March 2025
-
0
-
0
-
0
-
0
Carrying amount
At 31 March 2025
655,205
115,932
156,900
928,037
At 31 March 2024
688,210
30,475
83,700
802,385
6
Fixed asset investments
2025
2024
£
£
Other investments other than loans
171,978
161,716
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 April 2024
161,716
Additions
10,262
At 31 March 2025
171,978
Carrying amount
At 31 March 2025
171,978
At 31 March 2024
161,716
SHRADALE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 8 -
7
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
67,037
60,380
Other debtors
36,005
31,684
103,042
92,064
8
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
8,889
16,756
Trade creditors
128,081
85,124
Taxation and social security
93,029
49,959
Other creditors
833,296
1,304,617
1,063,295
1,456,456
9
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
843,529
487,504
Other creditors
11,628
18,972
855,157
506,476
Creditors which fall due after five years are as follows:
2025
2024
£
£
Payable by instalments
807,973
411,672
2025-03-31 2024-04-01 false false false 10 November 2025 CCH Software CCH Accounts Production 2025.300 No description of principal activity Mrs L J Dale Mrs M S Dale Mr T D Dale 09676488 2024-04-01 2025-03-31 09676488 2025-03-31 09676488 2024-03-31 09676488 core:NetGoodwill 2025-03-31 09676488 core:NetGoodwill 2024-03-31 09676488 core:LandBuildings 2025-03-31 09676488 core:OtherPropertyPlantEquipment 2025-03-31 09676488 core:LandBuildings 2024-03-31 09676488 core:OtherPropertyPlantEquipment 2024-03-31 09676488 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 09676488 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 09676488 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 09676488 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 09676488 core:CurrentFinancialInstruments 2025-03-31 09676488 core:CurrentFinancialInstruments 2024-03-31 09676488 core:Non-currentFinancialInstruments 2025-03-31 09676488 core:Non-currentFinancialInstruments 2024-03-31 09676488 core:ShareCapital 2025-03-31 09676488 core:ShareCapital 2024-03-31 09676488 core:RetainedEarningsAccumulatedLosses 2025-03-31 09676488 core:RetainedEarningsAccumulatedLosses 2024-03-31 09676488 bus:Director3 2024-04-01 2025-03-31 09676488 core:Goodwill 2024-04-01 2025-03-31 09676488 core:LandBuildings core:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 09676488 core:LeaseholdImprovements 2024-04-01 2025-03-31 09676488 core:PlantMachinery 2024-04-01 2025-03-31 09676488 core:MotorVehicles 2024-04-01 2025-03-31 09676488 core:BearerBiologicalAssetClass1 2024-04-01 2025-03-31 09676488 core:ConsumableBiologicalAssetClass1 2024-04-01 2025-03-31 09676488 core:BearerBiologicalAssetClass4 2024-04-01 2025-03-31 09676488 2023-04-01 2024-03-31 09676488 core:NetGoodwill 2024-03-31 09676488 core:NetGoodwill 2024-04-01 2025-03-31 09676488 core:LandBuildings 2024-03-31 09676488 core:OtherPropertyPlantEquipment 2024-03-31 09676488 2024-03-31 09676488 core:LandBuildings 2024-04-01 2025-03-31 09676488 core:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 09676488 core:BearerBiologicalAssetClass1 2024-03-31 09676488 core:ConsumableBiologicalAssetClass1 2024-03-31 09676488 core:BearerBiologicalAssetClass4 2024-03-31 09676488 core:BearerBiologicalAssetClass1 2025-03-31 09676488 core:ConsumableBiologicalAssetClass1 2025-03-31 09676488 core:BearerBiologicalAssetClass4 2025-03-31 09676488 core:BearerBiologicalAssetClass1 core:ImmatureBiologicalAssets 2024-04-01 2025-03-31 09676488 core:ConsumableBiologicalAssetClass1 core:ImmatureBiologicalAssets 2024-04-01 2025-03-31 09676488 core:BearerBiologicalAssetClass4 core:ImmatureBiologicalAssets 2024-04-01 2025-03-31 09676488 core:ImmatureBiologicalAssets 2024-04-01 2025-03-31 09676488 core:BearerBiologicalAssetClass1 2024-03-31 09676488 core:ConsumableBiologicalAssetClass1 2024-03-31 09676488 core:BearerBiologicalAssetClass4 2024-03-31 09676488 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09676488 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 09676488 bus:FRS102 2024-04-01 2025-03-31 09676488 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 09676488 bus:Director1 2024-04-01 2025-03-31 09676488 bus:Director2 2024-04-01 2025-03-31 09676488 bus:FullAccounts 2024-04-01 2025-03-31 xbrli:pure xbrli:shares iso4217:GBP